Please login to the form below

Not currently logged in
Email:
Password:

Aprecia

This page shows the latest Aprecia news and features for those working in and with pharma, biotech and healthcare.

3D printed epilepsy drug launched in the US

3D printed epilepsy drug launched in the US

3D printed epilepsy drug launched in the US. Aprecia’ s Spritam is now available as a prescription drug. ... Aprecia Pharmaceutical's Spritam was approved by the FDA in August last year, with industry experts hailing it as the catalyst for a new era in

Latest news

  • Printable pharma Printable pharma

    Spritam is designed to fill a need for patients who struggle with their current medication experience,” commented Don Wetherhold, Aprecia's chief executive. “ ... This is the first in a line of central nervous system products Aprecia plans to

  • FDA approves world’s first 3D printed drug FDA approves world’s first 3D printed drug

    FDA approves world’ s first 3D printed drug. Aprecia’ s epilepsy treatment Spritam seen as the future of drug manufacturing. ... experience. "This is the first in a line of central nervous system products Aprecia plans to introduce as part of our

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics